Tue 2/25/2020 08:53 ET
DJIA27960.80995.403.56%TELCO189.521.840.97%GOLD1653.6522.991.39%Shanghai3013.0518.080.60%
S&P 5003225.90108.073.35%BANKS480.4116.333.40%OIL51.290.140.27%BITCOIN9578.3068.960.72%
NASDAQ9221.28342.113.71%PHARM602.9814.532.41%US/EU1.080.000.00%Futures3239.3813.280.41%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  
From: AnthonyJackson (Rep: 0)Date: 01/18/2017 09:43
Forum: Neurocrine Biosciences - Msg #1113Thread #673900131 (Rec: 0)
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are trading lower by over 5% after the company announced disappointing phase II results for INGREZZA, a highly-selective small molecule Vesicular Monoamine Transporter 2 (VMAT2) inhibitor. Analysts are scrambling to find the proper price target and buy levels. Based on extensive stock chart analysis, the first major support level is at $32.75 The current stock price is $38.00. This will be a buy level for investors looking to pick up Neurocrine Biosciences on the cheap for a swing trade.
Stock market investors buy the Neurocrine Biosciences chart

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser AnthonyJackson: Reward | Watch | IgnoreNBIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.